Innovative Medicines Canada Proposes Framework for Innovative Drug Reimbursement Agreements | JD Supra
Pharmaceutical manufacturers in Canada often enter into product listing agreements, particularly with public payers, to facilitate reimbursement for their drugs. It is common for PLAs to take the form of a first-dollar rebate, with a gradual rebate if the annual amount to be repaid by the payer exceeds a certain threshold. However, this approach of …